Pathological and pharmacological functions of the metabolites of polyunsaturated fatty acids mediated by cyclooxygenases, lipoxygenases, and cytochrome P450s in cancers-Reference-Cited by-同舟云学术

Pathological and pharmacological functions of the metabolites of polyunsaturated fatty acids mediated by cyclooxygenases, lipoxygenases, and cytochrome P450s in cancers

Published:2024-04 Issue: Volume:256 Page:108612
ISSN:0163-7258
Container-title:Pharmacology & Therapeutics
language:en
Short-container-title:Pharmacology & Therapeutics

Author:

Meng Yi-Wen,Liu Jun-Yan

Funder

National Natural Science Foundation of China

Publisher

Elsevier BV

Reference367 articles.

1. A comparative study: The prospective influence of nanovectors in leveraging the chemopreventive potential of COX-2 inhibitors against skin cancer;Abo Aasy;International Journal of Nanomedicine,2019

2. Inhibition of 12-LOX and COX-2 reduces the proliferation of human epidermoid carcinoma cells (A431) by modulating the ERK and PI3K-Akt signalling pathways;Agarwal;Experimental Dermatology,2009

3. 8-Geranyloxycarbostyril as a potent 15-LOX-1 inhibitor showed great anti-tumor effects against prostate cancer;Aghasizadeh;Life Sciences,2022

4. Down-regulation of 20-HETE synthesis and signaling inhibits renal adenocarcinoma cell proliferation and tumor growth;Alexanian;Anticancer Research,2009

5. Cyclooxygenase-2 immunohistochemical expression is associated with worse prognosis in breast cancer: Retrospective study and literature review;Al-Maghrabi;Saudi Medical Journal,2022

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 5-Fluorouracil in Combination with Calcium Carbonate Nanoparticles Loaded with Antioxidant Thymoquinone against Colon Cancer: Synergistically Therapeutic Potential and Underlying Molecular Mechanism;Antioxidants;2024-08-25

2. The analgesic effects of Yu-Xue-Bi tablet (YXB) on mice with inflammatory pain by regulating LXA4-FPR2-TRPA1 pathway;Chinese Medicine;2024-08-06

3. Exosomes as novel tools for renal cell carcinoma therapy, diagnosis, and prognosis;Heliyon;2024-06